Alan S. Coates - Concepedia

Author

Alan S. Coates

Also Known As

A Coates, A Goldhirsch, A S Coates, A. COATES, A. Coates, A. Goldhirsch, A. S. COATES, A. S. Coates, A.S Coates, A.S. Coates

418

Publications

52.9K

Citations

H-Index

179

Concepts

All Affiliations

The University of Sydney International Breast Cancer Study Group European Institute of Oncology Dana-Farber Cancer Institute Frontier Science & Technology Research Foundation

About

Alan S. Coates is an author at The University of Sydney specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	114	20K
2	Health Sciences	19	24	9.7K
3	Nursing	10	11	7.9K
4	Engineering	1	1	17
5	Law	1	1	24

Alan S. Coates

207

Publications

39.2K

Citations

H-Index

Page 1

	Year	Citations
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Aron Goldhirsch, W. C. Wood, Alan S. Coates, Annals of Oncology	2011	3.8K
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Annals of Oncology Surgical OncologyBreast OncologyCancer ManagementPrimary TherapyPathology	2013	3.6K
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan S. Coates, Eric P. Winer, Aron Goldhirsch, Annals of Oncology	2015	1.8K
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer R. Charles Coombes, Emma Hall, Lorna J. Gibson, New England Journal of Medicine	2004	1.8K
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 Aron Goldhirsch, James N. Ingle, Richard D. Gelber, Annals of Oncology	2009	1.4K
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial Viviana Galimberti, Bernard F. Cole, Stefano Zurrida, The Lancet Oncology Ibcsg 23–01Surgical PathologySentinel-node MicrometastasesSurgeryAxillary Dissection	2013	1.2K
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 Aron Goldhirsch, John H. Glick, Richard D. Gelber, Annals of Oncology Breast OncologyMedicineCancer ManagementPrimary TherapyBreast Cancer	2005	1.1K
On the receiving end—patient perception of the side-effects of cancer chemotherapy Alan S. Coates, Suzanne Abraham, S.B. Kaye, European Journal of Cancer and Clinical Oncology Palliative CareMedicineCancer ManagementMetronomic TherapyPharmacotherapy	1983	1K
Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 Alan S. Coates, Aparna Keshaviah, Beat Thürlimann, Journal of Clinical Oncology	2007	897
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer Olivia Pagani, Meredith M. Regan, Barbara Walley, New England Journal of Medicine	2014	738

Page 1